Cargando…
Protease inhibitor GC376 for COVID-19: Lessons learned from feline infectious peritonitis
The main protease (M(pro)) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an important therapeutic target as it plays a major role in the processing and maturation of the viral polyprotein. GC376 is a pre-clinical dipeptide-based protease inhibitor that has been previously used f...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7797473/ https://www.ncbi.nlm.nih.gov/pubmed/33456770 http://dx.doi.org/10.1016/j.amsu.2020.12.030 |